OptimizeRx Corp (NASDAQ:OPRX) price on Thursday, July 03, rose 2.36% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $13.43.
A look at the stock’s price movement, the close in the last trading session was $13.12, moving within a range at $13.0 and $13.47. The beta value (5-Year monthly) was 1.332. Turning to its 52-week performance, $15.71 and $3.78 were the 52-week high and 52-week low respectively. Overall, OPRX moved 1.59% over the past month.
OptimizeRx Corp’s market cap currently stands at around $248.39 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-12.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OPRX is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend OPRX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OPRX’s current price about -2.56% and 12.58% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.11, while 7-day volatility ratio is 5.11% and 6.52% in the 30-day chart. Further, OptimizeRx Corp (OPRX) has a beta value of 1.34. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $15 and high of $15. Looking at the price targets, the low is -11.69% off current price level while to achieve the yearly target high, price needs to move -11.69%. Nonetheless, investors will most likely welcome a -11.69% jump to $15 which is the analysts’ median price.
If we refocus on OptimizeRx Corp (NASDAQ:OPRX), historical trading data shows that trading volumes averaged 0.26 over the past 10 days and 292.59K over the past 3 months. The company’s latest data on shares outstanding shows there are 18.49 million shares.
The 9.41% of OptimizeRx Corp’s shares are in the hands of company insiders while institutional holders own 64.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.57 million on 2025-06-13, giving us a short ratio of 3.83. The data shows that as of 2025-06-13 short interest in OptimizeRx Corp (OPRX) stood at 900.0 of shares outstanding, with shares short falling to 1.64 million registered in 2025-05-15. Current price change has pushed the stock 34.43% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OPRX stock continues to rise going into the next quarter.
